Expansion of Serotype Coverage in the Universal Pediatric Vaccination Calendar: Short-Term Effects on Age- and Serotype-Dependent Incidence of Invasive Pneumococcal Clinical Presentations in Madrid, Spain

Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults

(2012) Rebecca A Gladstone et al.   Expert Review of Vaccines

The Worldwide Impact of the Seven-valent Pneumococcal Conjugate Vaccine

(2012) Sean P. Fitzwater et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Impact of Introduction of Conjugate Vaccines in the Vaccination Schedule on the Incidence of Pediatric Invasive Pneumococcal Disease Requiring Hospitalization in Madrid 2007 to 2011

(2012) Juan Picazo et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Mathematical Modelling Long-Term Effects of Replacing Prevnar7 with Prevnar13 on Invasive Pneumococcal Diseases in England and Wales

(2012) Yoon Hong Choi et al.   PLoS One

Serotype 3 is a common serotype causing invasive pneumococcal disease in children less than 5 years old, as identified by real-time PCR

(2011) L. Selva et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Laboratory-based, 2-year Surveillance of Pediatric Parapneumonic Pneumococcal Empyema Following Heptavalent Pneumococcal Conjugate Vaccine Universal Vaccination in Madrid

(2011) Juan Picazo et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Clinical Presentation of Invasive Pneumococcal Disease in Spain in the Era of Heptavalent Conjugate Vaccine

(2011) Maria F. de Sevilla et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Invasive pneumococcal disease: Association between serotype, clinical presentation and lethality

(2011) Mª Angeles Gutiérrez Rodríguez et al.   VACCINE

Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain)

(2011) Javier Díez-Domingo et al.   VACCINE

Clonal and clinical profile of Streptococcus pneumoniae serotype 19A causing pediatric invasive infections: A 2-year (2007–2009) laboratory-based surveillance in Madrid

(2011) J. Picazo et al.   VACCINE

Relationship between Serotypes, Age, and Clinical Presentation of Invasive Pneumococcal Disease in Madrid, Spain, after Introduction of the 7-Valent Pneumococcal Conjugate Vaccine into the Vaccination Calendar

(2010) J. Picazo et al.   Clinical and Vaccine Immunology

Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system?

(2010) Germaine Hanquet et al.   VACCINE

Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines

(2009) Daniel J. Isaacman et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain

(2009) C. Ardanuy et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Temporal Trends of Invasive Streptococcus pneumoniae Serotypes and Antimicrobial Resistance Patterns in Spain from 1979 to 2007

(2009) A. Fenoll et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Direct Serogrouping of Streptococcus pneumoniae Strains in Clinical Samples by Use of a Latex Agglutination Test

(2009) J. C. Sanz et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona

(2009) Carmen Muñoz-Almagro et al.   JOURNAL OF INFECTION

Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine

(2009) Tamara Pilishvili et al.   JOURNAL OF INFECTIOUS DISEASES